Mark W D Sweep Martijn J H Tjan Mark A J Gorris Kalijn F Bol Harm Westdorp
10.3389/fimmu.2023.1212432
Front Immunol
2023 Jun 26;14:1212432.
adverse event autoimmunity cancer case report colitis immune checkpoint inhibitor tofacitinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/37435072/
Colitis / chemically induced Colitis / drug therapy Immunosuppressive Agents
Colitis / chemically induced Colitis / drug therapy Immunosuppressive Agents Case Reports Research Support, Non-U.S. Gov't B7-H1 Antigen Humans Immune Checkpoint Inhibitors Ipilimumab / adverse effects Male Nivolumab Immunosuppressive Agents Immune Checkpoint Inhibitors tofacitinib Ipilimumab B7-H1 Antigen Nivolumab
PMC10331137
37435072
Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib
2023